These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 807008)

  • 1. Permeability of normal and cancerous rat bladder to antineoplastic agents.
    Bessman JD; Johnson RK; Goldin A
    Urology; 1975 Aug; 6(2):187-93. PubMed ID: 807008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical and systemic chemotherapy of murine bladder cancer.
    Soloway MS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
    [No Abstract]   [Full Text] [Related]  

  • 4. Single and sequential combination intravesical chemotherapy of murine bladder cancer.
    Soloway MS; Nissenkorn I; McCallum LW; Murphy WM
    Urology; 1982 Feb; 19(2):169-75. PubMed ID: 6800090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and experimental projects on chemotherapy of bladder tumours.
    Pavone-Macaluso M; Rausa L; Gebbia N; Caramia G; Rizzo FP; Arena E; Tessitore V; Vecchioni M
    S Afr Med J; 1974 Mar; 48(15):631-6. PubMed ID: 4378338
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of topical instillation of adriamycin in bladder tumors of rats fed with FANFT.
    Pontes JE; Izbicki R; Silberberg B; Baker L; Pierce JM
    Invest Urol; 1978 Jan; 15(4):278-9. PubMed ID: 627470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphologic effects of mitomycin C in mammalian urinary bladder.
    Murphy WM; Soloway MS; Crabtree WN
    Cancer; 1981 Jun; 47(11):2567-74. PubMed ID: 6790156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
    Daskal Y; Soloway MS; DeFuria MD; Crooke ST
    Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis.
    Cohen SM; Arai M; Jacobs JB; Friedell GH
    Cancer Res; 1979 Apr; 39(4):1207-17. PubMed ID: 421204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
    Merk FB; Pauli BU; Jacobs JB; Alroy J; Friedell GH; Weinstein RS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2843-53. PubMed ID: 872113
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular changes in rat urinary bladder carcinomas induced by FANFT: a quantitative electron microscopic analysis.
    Pauli BU; Cohen SM; Weinstein RS
    J Urol; 1983 Mar; 129(3):646-52. PubMed ID: 6834570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminal plasma membrane alterations in bladder cancer.
    Caruthers JM; Bonneville MA
    Invest Urol; 1980 Mar; 17(5):364-72. PubMed ID: 6987189
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.
    Masters JR; McDermott BJ; Harland S; Bibby MC; Loadman PM
    Cancer Chemother Pharmacol; 1996; 38(1):59-64. PubMed ID: 8603453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of FANFT induced bladder tumours in rats by intravesical DNCB instillation.
    Johnson DK; Pontes JE; Izbicki R; Pierce JM
    Urol Res; 1980; 8(1):23-4. PubMed ID: 7368458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental animal and clinical studies of the absorption of trisaziridylthiophosphoric acid (Thio-Thepa) from the bladder].
    Lunglmayr G; Czech K
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(6):421-8. PubMed ID: 4996544
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison between a purified and standard diet on FANFT-induced murine bladder cancer.
    Soloway MS; Nissenkorn I; McCallum LW
    Urology; 1981 Nov; 18(5):482-4. PubMed ID: 7314340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability of the bladder mucosa to thiotepa, adriamycin, and daunomycin in men and rabbits.
    Pavone-Macaluso M; Gebbia N; Biondo F; Bertolini S; Caramia G; Rizzo FP
    Urol Res; 1976 Apr; 4(1):9-13. PubMed ID: 821200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Wang CY; Hayashida S; Pamukcu AM; Bryan GT
    Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion in urinary bladder carcinogenesis.
    Cohen SM
    Environ Health Perspect; 1983 Apr; 50():51-9. PubMed ID: 6873031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.